Literature DB >> 30512224

IL-10 producing CD8+ CD122+ PD-1+ regulatory T cells are expanded by dendritic cells silenced for Allograft Inflammatory Factor-1.

Diana M Elizondo1, Temesgen E Andargie1, Naomi L Haddock1, Ricardo L Louzada da Silva2, Tatiana Rodrigues de Moura2, Michael W Lipscomb1.   

Abstract

Allograft Inflammatory Factor-1 (AIF1) is a cytoplasmic scaffold protein that contains Ca2+ binding EF-hand and PDZ interaction domains important for mediating intracellular signaling complexes in immune cells. The protein plays a dominant role in both macrophage- and dendritic cell (DC)-mediated inflammatory responses. This study now reports that AIF1 expression in DC is important in directing CD8+ T cell effector responses. Silencing AIF1 expression in murine CD11c+ DC suppressed antigen-specific CD8+ T cell activation, marked by reduced CXCR3, IFNγ and Granzyme B expression, and restrained proliferation. These primed CD8+ T cells had impaired cytotoxic killing of target cells in vitro. In turn, studies identified that AIF1 silencing in DC robustly expanded IL-10 producing CD8+ CD122+ PD-1+ regulatory T cells that suppressed neighboring immune effector responses through both IL-10 and PD-1-dependent mechanisms. In vivo studies recapitulated bystander suppression of antigen-responsive CD4+ T cells by the CD8+ Tregs expanded from the AIF1 silenced DC. These studies further demonstrate that AIF1 expression in DC serves as a potent governor of cognate T cell responses and present a novel target for engineering tolerogenic DC-based immunotherapies. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  Tregs; cytotoxic T cells; dendritic cells; programmed death-1; suppression; tolerogenic

Mesh:

Substances:

Year:  2018        PMID: 30512224      PMCID: PMC6310075          DOI: 10.1002/JLB.1A0118-010RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  32 in total

1.  Antigen specific killing assay using CFSE labeled target cells.

Authors:  Marina Durward; Jerome Harms; Gary Splitter
Journal:  J Vis Exp       Date:  2010-11-09       Impact factor: 1.355

2.  Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli.

Authors:  Ying Tian; Sheri E Kelemen; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2005-11-16       Impact factor: 4.249

3.  Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor.

Authors:  D M Elizondo; T E Andargie; K M Marshall; A M Zariwala; M W Lipscomb
Journal:  J Leukoc Biol       Date:  2016-06-17       Impact factor: 4.962

4.  Allograft inflammatory factor-1 augments production of interleukin-6, -10 and -12 by a mouse macrophage line.

Authors:  K Watano; K Iwabuchi; S Fujii; N Ishimori; S Mitsuhashi; M Ato; A Kitabatake; K Onoé
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

5.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

6.  Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.

Authors:  U Utans; R J Arceci; Y Yamashita; M E Russell
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

7.  Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

Authors:  Manish J Butte; Mary E Keir; Theresa B Phamduy; Arlene H Sharpe; Gordon J Freeman
Journal:  Immunity       Date:  2007-07-12       Impact factor: 31.745

8.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

9.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  13 in total

1.  Allograft inflammatory factor-1 in myeloid cells drives autoimmunity in type 1 diabetes.

Authors:  Diana M Elizondo; Nailah Zd Brandy; Ricardo L da Silva; Tatiana R de Moura; Michael W Lipscomb
Journal:  JCI Insight       Date:  2020-05-21

2.  Compromised DNA Repair Promotes the Accumulation of Regulatory T Cells With an Aging-Related Phenotype and Responsiveness.

Authors:  Daan K J Pieren; Noortje A M Smits; Sandra Imholz; Bhawani Nagarajah; Conny T van Oostrom; Renata M C Brandt; Wilbert P Vermeij; Martijn E T Dollé; Teun Guichelaar
Journal:  Front Aging       Date:  2021-05-11

Review 3.  CXCR5+CD8+ T cells: A Review of their Antibody Regulatory Functions and Clinical Correlations.

Authors:  Steven M Elzein; Jason M Zimmerer; Jing L Han; Bryce A Ringwald; Ginny L Bumgardner
Journal:  J Immunol       Date:  2021-06-15       Impact factor: 5.426

4.  Response kinetics reveal novel features of ageing in murine T cells.

Authors:  Daan K J Pieren; Noortje A M Smits; Martijn D B van de Garde; Teun Guichelaar
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

5.  Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB in vitro.

Authors:  Diana M Elizondo; Nailah Z D Brandy; Ricardo L L da Silva; Naomi L Haddock; Apollo D Kacsinta; Tatiana R de Moura; Michael W Lipscomb
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

6.  Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria Plasmodium yoelii.

Authors:  Takashi Imai; Kazutomo Suzue; Ha Ngo-Thanh; Suguri Ono; Wakako Orita; Haruka Suzuki; Chikako Shimokawa; Alex Olia; Seiji Obi; Tomoyo Taniguchi; Hidekazu Ishida; Luc Van Kaer; Shigeo Murata; Keiji Tanaka; Hajime Hisaeda
Journal:  Front Immunol       Date:  2019-09-25       Impact factor: 7.561

7.  Leishmania donovani infection suppresses Allograft Inflammatory Factor-1 in monocytes and macrophages to inhibit inflammatory responses.

Authors:  Ricardo Louzada da Silva; Diana M Elizondo; Nailah Z D Brandy; Naomi L Haddock; Thomas A Boddie; Laís Lima de Oliveira; Amélia Ribeiro de Jesus; Roque Pacheco de Almeida; Tatiana Rodrigues de Moura; Michael W Lipscomb
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 8.  Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease.

Authors:  Sara Ness; Shiming Lin; John R Gordon
Journal:  Front Immunol       Date:  2021-03-10       Impact factor: 7.561

Review 9.  Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity.

Authors:  Ting-Ting Sheu; Bor-Luen Chiang
Journal:  Int J Mol Sci       Date:  2021-04-16       Impact factor: 5.923

Review 10.  Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.

Authors:  Xiaoyu Wang; Yumin Xia
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.